Abcam (ABCZF) Receivables Turnover : 2.59 (As of Jun. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Abcam Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Abcam's Revenue for the six months ended in Jun. 2023 was $256.6 Mil. Abcam's average Accounts Receivable for the six months ended in Jun. 2023 was $99.1 Mil. Hence, Abcam's Receivables Turnover for the six months ended in Jun. 2023 was 2.59.

Abcam Receivables Turnover Historical Data

The historical data trend for Abcam's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abcam Receivables Turnover Chart

Abcam Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Dec22

Receivables Turnover

Get a 7-Day Free Trial

9.93

10.12

7.51

6.93

7.29

Abcam Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Receivables Turnover	Get a 7-Day Free Trial															3.85	3.27	3.24	2.73	2.59

Competitive Comparison of Abcam's Receivables Turnover

For the Biotechnology subindustry, Abcam's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abcam's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abcam's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Abcam's Receivables Turnover falls into.

Abcam Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Abcam's Receivables Turnover for the fiscal year that ended in Dec. 2022 is calculated as

	Receivables Turnover (A: Dec. 2022 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2022 )	/ (	(Accounts Receivable (A: Jun. 2020 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )
=	440.56	/ (	(39.299	+	81.608)	/	2 )
=	440.56	/	60.4535
=	7.29

Abcam's Receivables Turnover for the quarter that ended in Jun. 2023 is calculated as

	Receivables Turnover (Q: Jun. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jun. 2023 )	/ (	(Accounts Receivable (Q: Dec. 2022 )	+	Accounts Receivable (Q: Jun. 2023 ))	/	count )
=	256.566	/ (	(81.608	+	116.54)	/	2 )
=	256.566	/	99.074
=	2.59

Abcam (OTCPK:ABCZF) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Abcam Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Abcam's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Abcam (ABCZF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (OTCPK:ABCZF) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

Discovery Drive, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AX

Website

https://www.abcam.com

Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.